Our core expertise
Biologics
- Biosimilars & Novel Biologics
Monoclonal antibodies, bi-specific and multi-specific antibodies - Next-Generation Antibody Platforms
Antibody–Drug Conjugates (ADCs), nanobodies, single-domain antibodies - Antibody Fragments
Fab, scFv, and F(ab’)₂ for targeted and precision therapies - Protein & Peptide Therapeutics
Cytokines and chemokines, growth factors, synthetic and recombinant peptides - Fusion & Plasma-Derived Proteins
Complex biologics addressing unmet medical needs - Vaccines
Viral and bacterial vaccines, virus-like particles (VLPs), polysaccharide and conjugate vaccines
Advanced Therapies
- Cell Therapies
CAR-T and CAR-NK therapies, TCR-engineered T cells for advanced cancer treatment - Stem Cell Therapies
Embryonic stem cells (ESC), induced pluripotent stem cells (iPSC), and adult stem cells - Exosome & Extracellular Vesicle Therapies
Emerging platforms for targeted delivery and regenerative medicine - Viral Vector Technologies
AAV, lentiviral, and retroviral vectors for gene and cell-based therapies - Non-Viral Gene Delivery Systems
mRNA, siRNA, miRNA, and RNAi-based therapeutic approaches - Gene Editing Technologies
CRISPR/Cas, TALENs, and zinc finger nucleases (ZFNs)
Small Molecules
- Medicinal Chemistry
Lead optimization and candidate selection - Process Chemistry
Route scouting, optimization, and impurity control - Process Development & Scale-Up
Robust scale-up for small molecules and biologics - Finished Dosage Form Development
Formulation development and manufacturing readiness
Medical Devices
- Molecular Diagnostics
Precision tools for genetic and biomarker-based decision-making - Immunodiagnostics
Targeted detection supporting biologics and immunotherapies - AI-Based Precision Diagnostics
Data-driven insights enabling personalized treatment strategies - Organoids based drug screening
- Biologics & Companion Diagnostics
Integrated diagnostic approaches to optimize therapeutic outcomes - Implantable Medical Devices
Advanced device development incorporating small molecules to enhance patient outcomes
Advanced Dermocosmetics & Biotech Actives
- Plant Stem Cell Based Actives
Next-generation ingredients for advanced skincare solutions - Exosome-Based Actives
Innovative regenerative and signaling technologies - Dermocosmetics & Clinical Skincare
Science-driven formulations with clinical relevance - Anti-Aging & Regenerative Cosmetics
Solutions focused on skin repair, rejuvenation, and longevity - Preservative-Free Formulations
Clean, safe, and high-performance product development - Biologics & Small-Molecule Integration
Strategic consulting to combine biologics and small molecules for optimized skincare outcomes